Corvus Pharmaceuticals (CRVS) Share-based Compensation (2015 - 2026)
Corvus Pharmaceuticals (CRVS) reported Share-based Compensation of $2.61 million for Q2 2026, up 107.7% from $1.26 million a year earlier but down 1.5% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Share-based Compensation (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Corvus Pharmaceuticals' Share-based Compensation came in at $8.08 million, up 99.4% year-over-year; for FY2025, it was $5.33 million, up 77.5% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $3 million in FY2024 (+39.9%), $2.15 million in FY2023 (-20.2%), $2.69 million in FY2022 (-36.4%) and $4.23 million in FY2021 (-26.4%).
- Five-year quarterly Share-based Compensation spans a low of $492,000 in Q1 2023 and a high of $2.65 million in Q1 2026.
- Year over year, Share-based Compensation has now increased in each of the last ten quarters, with growth averaging 75.6% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q1 2026 (growth of 111.8%); the low point was Q2 2022 (a decline of 42.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.65 million (Q1 2026), $1.57 million (Q4 2025) and $1.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Corvus Pharmaceuticals | 998.52 Mn | 486.96 Mn | - | 2.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.61 Mn |
| Mar 31, 2026 | 2.65 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.25 Mn |
| Dec 31, 2024 | 812,000.00 |
| Sep 30, 2024 | 734,000.00 |
| Jun 30, 2024 | 769,000.00 |
| Mar 31, 2024 | 689,000.00 |
| Dec 31, 2023 | 572,000.00 |
| Sep 30, 2023 | 546,000.00 |
| Jun 30, 2023 | 537,000.00 |
| Mar 31, 2023 | 492,000.00 |
| Dec 31, 2022 | 620,000.00 |
| Sep 30, 2022 | 658,000.00 |
| Jun 30, 2022 | 675,000.00 |
| Mar 31, 2022 | 739,000.00 |
| Dec 31, 2021 | 738,000.00 |
| Sep 30, 2021 | 1.10 Mn |
API Access
Corvus Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();